Koninklijke Philips | PHG - Cost Of Sales


Koninklijke Philips reported EUR2.14B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Abbott USD 5.94B 642M Jun/2026
Baxter International USD 1.93B 118M Jun/2026
Becton, Dickinson and Co. USD 2.67B 108M Jun/2026
Boston Scientific USD 1.86B 29M Jun/2026
Danaher USD 2.65B 294M Jun/2026
Demant DKK 2.96B 61M Jun/2026
Dexcom USD 478.4M 36.8M Jun/2026
Edwards Lifesciences USD 392.4M 29.8M Jun/2026
Fresenius EUR 4.4B 111M Jun/2026
General Electric Aerospace USD 8.89B 736M Jun/2026
Getinge SEK 3.97B 2.05B Jun/2026
Globus Medical USD 271M 7.41M Jun/2026
GN Store Nord DKK 1.09B 67M Jun/2026
Hitachi JPY 1.9T 240.43B Jun/2026
Idexx Laboratories USD 437.5M 19.42M Jun/2026
Insulet USD 239.1M 6.4M Jun/2026
Integra LifeSciences USD 188.86M 10.15M Jun/2026
Intuitive Surgical USD 931.9M 8.4M Jun/2026
J&J USD 8B 67M Jun/2026
Koninklijke Philips EUR 2.14B 1.13B Mar/2026
Medtronic USD 3.83B 26M Jun/2026
Philips EUR 2.21B 70M Jun/2026
ResMed USD 612.93M 61.26M Jun/2026
Smith & Nephew USD 901M 31M Jun/2026
Steris USD 808.6M 82.7M Jun/2026
Stryker USD 2.26B 106M Jun/2026
Teleflex USD 238.62M 2.21M Jun/2026
Terumo JPY 133.27B 18.03B Jun/2026
Zimmer Biomet Holdings USD 815.9M 77.6M Jun/2026